Important note

This AI stock analysis for Shattuck Labs is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Shattuck Labs - AI Stock Analysis

Analysis generated December 20, 2024

Shattuck Labs is a biotechnology company that specializes in the development of novel therapeutics. The company's innovative approach focuses on leveraging its proprietary Agonist Redirected Checkpoint (ARC) platform to enhance the immune system’s ability to fight cancer and other diseases. Shattuck Labs is dedicated to improving the outcomes for patients with serious and life-threatening conditions through groundbreaking research and development.

Fundamental Analysis

For the last quarter, Shattuck Labs reported a revenue of $3 million. This represents an impressive increase of 86.26% compared to the quarter before it. When compared to the same quarter last year, this marks a phenomenal year-over-year growth of 336.88%. This is indicative of strong, positive momentum in the company's revenue streams and overall growth trajectory.

Shattuck Labs' net income for the last quarter was $17 million, an increase of 22.63% compared to the previous quarter. Compared to the same quarter last year, the increase is 39.45%. These figures highlight the company's improving profitability and operational efficiency.

The EBITDA for the last quarter was $18 million, showing an 18.55% increase from the previous quarter. When compared to the same quarter the previous year, it exhibits a 35.02% increase. This trend suggests robust growth in earnings and effective cost management.

Technical Analysis

Today’s stock price stands at $1.06, reflecting a 4.50% decrease compared to a month ago. Over a year, the stock has decreased by 83.57%, which is worrisome for long-term investors and indicates substantial loss of market value.

The stock displays a bearish trend with a current SMA10 of $1.14, which is lower than the previous SMA10 of $1.16. This suggests a potential downward trend in price movement. The Relative Strength Index (RSI) is at 80.3, which signals that the stock is potentially overbought and could see further declines.

Alternative Data Analysis

Regarding job postings and employee sentiment, Shattuck Labs currently has 0 open positions, which is down by 100% over the last few months. This could indicate cost-cutting measures, potentially troubling for growth prospects. However, employee sentiment remains high, with 87% of employees expressing a positive outlook on the company's future.

Customer acquisition metrics show an estimated 2,000 visitors to Shattuck Labs' webpage, a decrease of 67% over the last few months. This drop suggests potential issues with customer engagement and retention.

According to AltIndex’s AI score, Shattuck Labs received a score of 76, indicating a buy signal based on a combination of fundamental, technical, and alternative data points.

Conclusion

Shattuck Labs presents a mixed picture. The company shows robust growth in revenue, net income, and EBITDA, which are strong indicators of improving business health. However, the technical analysis suggests a bearish trend with significant stock price drops both in the short term and over the past year. The recent reduction in job postings and decrease in web traffic raise additional concerns about the company's immediate growth prospects.

Despite these concerns, the high AI score points towards a buying opportunity, possibly indicating that the stock is undervalued. Investors should weigh the high growth metrics and positive employee sentiment against the bearish technical signals and declining customer acquisition metrics before making a decision.

Recommendation: Based on the comprehensive analysis, Shattuck Labs shows potential but comes with certain risks. Cautious investors may consider a wait-and-see approach while closely monitoring the company's fundamental and technical trends.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.